Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_assertion description "[Interest in ADAM12 has increased recently because its expression is related to tumor progression and it is a potential biomarker for breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_assertion evidence source_evidence_literature NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_assertion SIO_000772 18342566 NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_assertion wasDerivedFrom befree-2016 NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_assertion wasGeneratedBy ECO_0000203 NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.
- befree-2016 importedOn "2016-02-19" NP660825.RAHcHzNv1UflPOO6X_ilenMGn8Z27py0m42o6EWpgoO-4130_provenance.